Stemetic en es it fr

Stemetic Brand names, Stemetic Analogs

Stemetic Brand Names Mixture

  • Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
  • Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)

Stemetic Chemical_Formula


Stemetic RX_link

No information avaliable

Stemetic fda sheet

Stemetic msds (material safety sheet)

Stemetic MSDS

Stemetic Synthesis Reference

No information avaliable

Stemetic Molecular Weight

280.285 g/mol

Stemetic Melting Point

No information avaliable

Stemetic H2O Solubility

No information avaliable

Stemetic State


Stemetic LogP


Stemetic Dosage Forms

Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)

Stemetic Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF).

Stemetic Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.

Stemetic Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.

Stemetic side effects and Toxicity

No information avaliable

Stemetic Patient Information

No information avaliable

Stemetic Organisms Affected

Humans and other mammals